U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H22FN7O3
Molecular Weight 463.4643
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMG-337

SMILES

COCCOC1=CC2=C(C=CN([C@H](C)C3=NN=C4N3C=C(C=C4F)C5=CN(C)N=C5)C2=O)N=C1

InChI

InChIKey=DWHXUGDWKAIASB-CQSZACIVSA-N
InChI=1S/C23H22FN7O3/c1-14(30-5-4-20-18(23(30)32)9-17(11-25-20)34-7-6-33-3)21-27-28-22-19(24)8-15(13-31(21)22)16-10-26-29(2)12-16/h4-5,8-14H,6-7H2,1-3H3/t14-/m1/s1

HIDE SMILES / InChI

Molecular Formula C23H22FN7O3
Molecular Weight 463.4643
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 01:47:20 UTC 2023
Edited
by admin
on Sat Dec 16 01:47:20 UTC 2023
Record UNII
08WG8S0L8D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMG-337
Common Name English
AMG 337 [WHO-DD]
Common Name English
1,6-NAPHTHYRIDIN-5(6H)-ONE, 6-((1R)-1-(8-FLUORO-6-(1-METHYL-1H-PYRAZOL-4-YL)-1,2,4-TRIAZOLO(4,3-A)PYRIDIN-3-YL)ETHYL)-3-(2-METHOXYETHOXY)-
Systematic Name English
Code System Code Type Description
ChEMBL
CHEMBL3545212
Created by admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
PRIMARY
CAS
1173699-31-4
Created by admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
PRIMARY
PUBCHEM
44181686
Created by admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
PRIMARY
NCI_THESAURUS
C95203
Created by admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
PRIMARY
DRUG BANK
DB15639
Created by admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
PRIMARY
SMS_ID
100000175796
Created by admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
PRIMARY
FDA UNII
08WG8S0L8D
Created by admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Little efficacy shown in Phase II trials.
IC50
SALT/SOLVATE -> PARENT
SOLVATE->ANHYDROUS
Related Record Type Details
ACTIVE MOIETY